25 XP   0   0   10

Bioera
Buy, Hold or Sell?

Let's analyse Bioera together

PenkeI guess you are interested in Bioera. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioera. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioera

I send you an email if I find something interesting about Bioera.

Quick analysis of Bioera (30 sec.)










What can you expect buying and holding a share of Bioera? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
€-0.25
Expected worth in 1 year
€-1.07
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€-0.82
Return On Investment
-926.3%

For what price can you sell your share?

Current Price per Share
€0.09
Expected price per share
€0.048 - €0.171
How sure are you?
50%

1. Valuation of Bioera (5 min.)




Live pricePrice per Share (EOD)

€0.09

Intrinsic Value Per Share

€-0.29 - €2.27

Total Value Per Share

€-0.54 - €2.03

2. Growth of Bioera (5 min.)




Is Bioera growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.4m-$1.3m-$4.1m-75.3%

How much money is Bioera making?

Current yearPrevious yearGrowGrow %
Making money-$4.2m$16.6m-$20.9m-489.9%
Net Profit Margin-712.1%1,306.6%--

How much money comes from the company's main activities?

3. Financial Health of Bioera (5 min.)




4. Comparing to competitors in the Conglomerates industry (5 min.)




  Industry Rankings (Conglomerates)  


Richest
#243 / 246

Most Revenue
#232 / 246

Most Profit
#213 / 246

Most Efficient
#241 / 246

What can you expect buying and holding a share of Bioera? (5 min.)

Welcome investor! Bioera's management wants to use your money to grow the business. In return you get a share of Bioera.

What can you expect buying and holding a share of Bioera?

First you should know what it really means to hold a share of Bioera. And how you can make/lose money.

Speculation

The Price per Share of Bioera is €0.089. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.25. Based on the TTM, the Book Value Change Per Share is €-0.21 per quarter. Based on the YOY, the Book Value Change Per Share is €0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioera.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.21-233.0%-0.21-233.0%0.54612.2%-0.06-66.3%-0.10-109.4%
Usd Book Value Change Per Share-0.22-247.8%-0.22-247.8%0.53594.5%-0.10-115.8%-0.12-135.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.0116.5%
Usd Total Gains Per Share-0.22-247.8%-0.22-247.8%0.53594.5%-0.10-115.8%-0.11-118.8%
Usd Price Per Share0.46-0.46-0.11-0.33-0.31-
Price to Earnings Ratio-2.22--2.22-0.20--1.37-0.14-
Price-to-Total Gains Ratio-2.08--2.08-0.21--1.05--1.16-
Price to Book Ratio-1.73--1.73--2.42--1.24--0.37-
Price-to-Total Gains Ratio-2.08--2.08-0.21--1.05--1.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0952211
Number of shares10501
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.22-0.10
Usd Total Gains Per Share-0.22-0.10
Gains per Quarter (10501 shares)-2,315.45-1,082.70
Gains per Year (10501 shares)-9,261.80-4,330.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-9262-92720-4331-4341
20-18524-185340-8662-8672
30-27785-277960-12992-13003
40-37047-370580-17323-17334
50-46309-463200-21654-21665
60-55571-555820-25985-25996
70-64833-648440-30316-30327
80-74094-741060-34647-34658
90-83356-833680-38977-38989
100-92618-926300-43308-43320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%4.08.06.022.2%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%7.011.00.038.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%3.00.07.030.0%3.00.015.016.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%7.011.00.038.9%

Fundamentals of Bioera

About Bioera

Bioera S.p.A. engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names; and distributes its products through outsourcers. The company was founded in 2004 and is headquartered in Milan, Italy.

Fundamental data was last updated by Penke on 2024-04-19 16:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bioera.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioera earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Net Profit Margin of -712.1% means that €-7.12 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioera:

  • The MRQ is -712.1%. The company is making a huge loss. -2
  • The TTM is -712.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-712.1%TTM-712.1%0.0%
TTM-712.1%YOY1,306.6%-2,018.8%
TTM-712.1%5Y107.7%-819.8%
5Y107.7%10Y51.3%+56.4%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-712.1%3.6%-715.7%
TTM-712.1%3.6%-715.7%
YOY1,306.6%3.8%+1,302.8%
5Y107.7%3.3%+104.4%
10Y51.3%3.7%+47.6%
1.1.2. Return on Assets

Shows how efficient Bioera is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • -138.4% Return on Assets means that Bioera generated €-1.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioera:

  • The MRQ is -138.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -138.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-138.4%TTM-138.4%0.0%
TTM-138.4%YOY95.0%-233.4%
TTM-138.4%5Y-20.2%-118.2%
5Y-20.2%10Y-13.5%-6.7%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-138.4%0.8%-139.2%
TTM-138.4%0.8%-139.2%
YOY95.0%1.1%+93.9%
5Y-20.2%0.8%-21.0%
10Y-13.5%0.9%-14.4%
1.1.3. Return on Equity

Shows how efficient Bioera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • 0.0% Return on Equity means Bioera generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioera:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-14.4%+14.4%
5Y-14.4%10Y-20.3%+5.9%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.9%-1.9%
TTM-2.4%-2.4%
YOY-3.2%-3.2%
5Y-14.4%2.4%-16.8%
10Y-20.3%2.5%-22.8%

1.2. Operating Efficiency of Bioera.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioera is operating .

  • Measures how much profit Bioera makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioera:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-231.9%+231.9%
TTM-5Y-58.4%+58.4%
5Y-58.4%10Y-30.8%-27.6%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%-7.8%
TTM-4.7%-4.7%
YOY-231.9%6.4%-238.3%
5Y-58.4%5.3%-63.7%
10Y-30.8%5.6%-36.4%
1.2.2. Operating Ratio

Measures how efficient Bioera is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Conglomerates industry mean).
  • An Operation Ratio of 6.06 means that the operating costs are €6.06 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Bioera:

  • The MRQ is 6.063. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.063. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.063TTM6.0630.000
TTM6.063YOY3.434+2.628
TTM6.0635Y3.248+2.814
5Y3.24810Y2.552+0.697
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0631.520+4.543
TTM6.0631.491+4.572
YOY3.4341.385+2.049
5Y3.2481.378+1.870
10Y2.5521.260+1.292

1.3. Liquidity of Bioera.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Conglomerates industry mean).
  • A Current Ratio of 0.07 means the company has €0.07 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioera:

  • The MRQ is 0.067. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.067. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.0670.000
TTM0.067YOY0.329-0.262
TTM0.0675Y0.371-0.304
5Y0.37110Y0.691-0.320
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0671.463-1.396
TTM0.0671.474-1.407
YOY0.3291.471-1.142
5Y0.3711.561-1.190
10Y0.6911.500-0.809
1.3.2. Quick Ratio

Measures if Bioera is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Quick Ratio of 0.02 means the company can pay off €0.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioera:

  • The MRQ is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.0160.000
TTM0.016YOY0.192-0.177
TTM0.0165Y0.237-0.221
5Y0.23710Y0.437-0.201
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0160.713-0.697
TTM0.0160.747-0.731
YOY0.1920.790-0.598
5Y0.2370.849-0.612
10Y0.4370.839-0.402

1.4. Solvency of Bioera.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioera assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioera to Conglomerates industry mean.
  • A Debt to Asset Ratio of 2.77 means that Bioera assets are financed with 277.1% credit (debt) and the remaining percentage (100% - 277.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioera:

  • The MRQ is 2.771. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.771. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.771TTM2.7710.000
TTM2.771YOY1.077+1.693
TTM2.7715Y1.548+1.223
5Y1.54810Y1.115+0.433
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7710.560+2.211
TTM2.7710.560+2.211
YOY1.0770.566+0.511
5Y1.5480.566+0.982
10Y1.1150.558+0.557
1.4.2. Debt to Equity Ratio

Measures if Bioera is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioera:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.070-1.070
5Y1.07010Y1.685-0.615
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.353-1.353
TTM-1.342-1.342
YOY-1.417-1.417
5Y1.0701.587-0.517
10Y1.6851.528+0.157

2. Market Valuation of Bioera

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Bioera generates.

  • Above 15 is considered overpriced but always compare Bioera to the Conglomerates industry mean.
  • A PE ratio of -2.22 means the investor is paying €-2.22 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioera:

  • The EOD is -0.459. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.216. Based on the earnings, the company is expensive. -2
  • The TTM is -2.216. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.459MRQ-2.216+1.757
MRQ-2.216TTM-2.2160.000
TTM-2.216YOY0.199-2.415
TTM-2.2165Y-1.373-0.843
5Y-1.37310Y0.138-1.511
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4597.719-8.178
MRQ-2.2167.538-9.754
TTM-2.2167.640-9.856
YOY0.1997.249-7.050
5Y-1.3739.536-10.909
10Y0.13815.800-15.662
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioera:

  • The EOD is 0.439. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.120. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 2.120. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.439MRQ2.120-1.681
MRQ2.120TTM2.1200.000
TTM2.120YOY-1.322+3.443
TTM2.1205Y1.728+0.393
5Y1.72810Y-0.401+2.128
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD0.4392.276-1.837
MRQ2.1202.364-0.244
TTM2.1201.302+0.818
YOY-1.3220.437-1.759
5Y1.7281.054+0.674
10Y-0.4010.539-0.940
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioera is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Conglomerates industry mean).
  • A PB ratio of -1.73 means the investor is paying €-1.73 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioera:

  • The EOD is -0.359. Based on the equity, the company is expensive. -2
  • The MRQ is -1.732. Based on the equity, the company is expensive. -2
  • The TTM is -1.732. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.359MRQ-1.732+1.373
MRQ-1.732TTM-1.7320.000
TTM-1.732YOY-2.424+0.692
TTM-1.7325Y-1.241-0.491
5Y-1.24110Y-0.371-0.869
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD-0.3590.947-1.306
MRQ-1.7320.976-2.708
TTM-1.7320.977-2.709
YOY-2.4241.120-3.544
5Y-1.2411.181-2.422
10Y-0.3711.448-1.819
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bioera compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.206-0.2060%0.495-142%-0.096-53%-0.113-45%
Book Value Per Share---0.248-0.2480%-0.042-83%-0.206-17%0.214-216%
Current Ratio--0.0670.0670%0.329-80%0.371-82%0.691-90%
Debt To Asset Ratio--2.7712.7710%1.077+157%1.548+79%1.115+149%
Debt To Equity Ratio----0%-0%1.070-100%1.685-100%
Dividend Per Share----0%-0%-0%0.014-100%
Eps---0.194-0.1940%0.509-138%-0.055-72%-0.091-53%
Free Cash Flow Per Share--0.2030.2030%-0.077+138%0.005+3779%-0.053+126%
Free Cash Flow To Equity Per Share---0.006-0.0060%-0.012+93%-0.016+149%-0.011+67%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.274--------
Intrinsic Value_10Y_min---0.293--------
Intrinsic Value_1Y_max--0.053--------
Intrinsic Value_1Y_min---0.048--------
Intrinsic Value_3Y_max--0.293--------
Intrinsic Value_3Y_min---0.129--------
Intrinsic Value_5Y_max--0.694--------
Intrinsic Value_5Y_min---0.192--------
Market Cap1830819.000-383%8835244.5008835244.5000%3058695.395+189%6490108.039+36%6112857.130+45%
Net Profit Margin---7.121-7.1210%13.066-155%1.077-761%0.513-1488%
Operating Margin----0%-2.3190%-0.5840%-0.3080%
Operating Ratio--6.0636.0630%3.434+77%3.248+87%2.552+138%
Pb Ratio-0.359+79%-1.732-1.7320%-2.424+40%-1.241-28%-0.371-79%
Pe Ratio-0.459+79%-2.216-2.2160%0.199-1212%-1.373-38%0.138-1709%
Price Per Share0.089-383%0.4300.4300%0.102+323%0.306+40%0.292+47%
Price To Free Cash Flow Ratio0.439-383%2.1202.1200%-1.322+162%1.728+23%-0.401+119%
Price To Total Gains Ratio-0.432+79%-2.084-2.0840%0.205-1115%-1.051-50%-1.156-45%
Quick Ratio--0.0160.0160%0.192-92%0.237-93%0.437-96%
Return On Assets---1.384-1.3840%0.950-246%-0.202-85%-0.135-90%
Return On Equity----0%-0%-0.1440%-0.2030%
Total Gains Per Share---0.206-0.2060%0.495-142%-0.096-53%-0.099-52%
Usd Book Value---5457559.900-5457559.9000%-1350213.800-75%-4629243.320-15%4668936.610-217%
Usd Book Value Change Per Share---0.220-0.2200%0.529-142%-0.103-53%-0.120-45%
Usd Book Value Per Share---0.265-0.2650%-0.045-83%-0.221-17%0.229-216%
Usd Dividend Per Share----0%-0%-0%0.015-100%
Usd Eps---0.207-0.2070%0.545-138%-0.059-72%-0.097-53%
Usd Free Cash Flow--4458273.3004458273.3000%-2474678.700+156%-42154.060+101%-1255313.670+128%
Usd Free Cash Flow Per Share--0.2170.2170%-0.082+138%0.006+3779%-0.057+126%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%-0.013+93%-0.017+149%-0.012+67%
Usd Market Cap1958793.248-383%9452828.0919452828.0910%3272498.203+189%6943766.591+36%6540145.843+45%
Usd Price Per Share0.095-383%0.4600.4600%0.109+323%0.327+40%0.313+47%
Usd Profit---4266761.200-4266761.2000%16635875.100-126%-211626.220-95%-1502995.520-65%
Usd Revenue--599144.000599144.0000%1273181.000-53%18273036.080-97%36576885.280-98%
Usd Total Gains Per Share---0.220-0.2200%0.529-142%-0.103-53%-0.106-52%
 EOD+3 -5MRQTTM+0 -0YOY+9 -215Y+11 -2010Y+11 -22

3.2. Fundamental Score

Let's check the fundamental score of Bioera based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.459
Price to Book Ratio (EOD)Between0-1-0.359
Net Profit Margin (MRQ)Greater than0-7.121
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.016
Current Ratio (MRQ)Greater than10.067
Debt to Asset Ratio (MRQ)Less than12.771
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.384
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Bioera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.189
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.058
Ma 100Greater thanMa 2000.055
OpenGreater thanClose0.092
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Invested Capital  15,076-12,4592,617-2,3023152,6913,006-8,107-5,101



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets2,881
Total Liabilities7,982
Total Stockholder Equity-5,101
 As reported
Total Liabilities 7,982
Total Stockholder Equity+ -5,101
Total Assets = 2,881

Assets

Total Assets2,881
Total Current Assets529
Long-term Assets2,352
Total Current Assets
Cash And Cash Equivalents 15
Short-term Investments 41
Other Current Assets 39
Total Current Assets  (as reported)529
Total Current Assets  (calculated)95
+/- 434
Long-term Assets
Property Plant Equipment 752
Long-term Assets  (as reported)2,352
Long-term Assets  (calculated)752
+/- 1,600

Liabilities & Shareholders' Equity

Total Current Liabilities7,868
Long-term Liabilities70
Total Stockholder Equity-5,101
Total Current Liabilities
Short Long Term Debt 2,995
Accounts payable 1,343
Other Current Liabilities 7
Total Current Liabilities  (as reported)7,868
Total Current Liabilities  (calculated)4,345
+/- 3,523
Long-term Liabilities
Long term Debt Total 51
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)70
Long-term Liabilities  (calculated)52
+/- 18
Total Stockholder Equity
Common Stock4,491
Retained Earnings -9,592
Total Stockholder Equity (as reported)-5,101
Total Stockholder Equity (calculated)-5,101
+/-0
Other
Capital Stock4,491
Cash And Equivalents41
Cash and Short Term Investments 82
Common Stock Shares Outstanding 4,282
Liabilities and Stockholders Equity 2,881
Net Debt 2,980
Net Invested Capital -5,101
Net Working Capital -7,339
Property Plant and Equipment Gross 762



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
39,572
87,599
112,962
111,915
116,447
91,508
38,387
45,476
46,818
41,834
41,847
41,377
41,037
34,173
29,723
21,571
16,687
16,370
2,881
2,88116,37016,68721,57129,72334,17341,03741,37741,84741,83446,81845,47638,38791,508116,447111,915112,96287,59939,572
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
21,222
20,867
20,137
20,697
16,670
14,194
8,691
5,285
3,357
529
5293,3575,2858,69114,19416,67020,69720,13720,86721,222000000000
       Cash And Cash Equivalents 
60
15,160
7,217
3,846
2,946
2,132
1,054
2,200
2,907
2,949
1,867
1,209
3,499
604
419
95
45
2
15
15245954196043,4991,2091,8672,9492,9072,2001,0542,1322,9463,8467,21715,16060
       Short-term Investments 
4,018
1,679
804
78
15
8
0
4,395
2,484
807
0
0
216
0
0
0
0
989
41
419890000216008072,4844,3950815788041,6794,018
       Net Receivables 
9,742
23,980
39,141
34,455
36,000
40,313
10,466
10,386
12,207
11,980
11,991
11,484
11,417
11,276
9,743
6,753
1,676
945
0
09451,6766,7539,74311,27611,41711,48411,99111,98012,20710,38610,46640,31336,00034,45539,14123,9809,742
       Other Current Assets 
213
375
490
2,594
2,618
1,322
0
52
58
2,084
2,614
2,708
474
88
379
185
278
1,057
39
391,057278185379884742,7082,6142,084585201,3222,6182,594490375213
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
20,340
17,503
15,529
12,880
11,402
13,013
2,352
2,35213,01311,40212,88015,52917,50320,340000000000000
       Property Plant Equipment 
8,628
7,516
8,321
7,877
8,201
12,391
3,762
3,626
2,622
1,595
3,078
3,809
4,277
3,910
3,643
2,984
2,757
888
752
7528882,7572,9843,6433,9104,2773,8093,0781,5952,6223,6263,76212,3918,2017,8778,3217,5168,628
       Goodwill 
8,532
14,968
28,118
29,160
30,444
16,928
11,605
11,442
12,078
11,442
11,442
11,442
7,675
7,092
6,346
5,957
5,755
0
0
005,7555,9576,3467,0927,67511,44211,44211,44212,07811,44211,60516,92830,44429,16028,11814,9688,532
       Long Term Investments 
0
0
0
0
0
0
0
0
0
4,306
1,284
2,156
3,604
4,161
4,095
0
0
0
0
00004,0954,1613,6042,1561,2844,306000000000
       Intangible Assets 
9,219
15,746
28,958
30,086
31,402
17,479
11,703
11,638
13,670
11,694
11,928
496
395
258
142
828
60
0
0
006082814225839549611,92811,69413,67011,63811,70317,47931,40230,08628,95815,7469,219
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
20,340
17,503
15,529
12,880
0
0
0
00012,88015,52917,50320,340000000000000
> Total Liabilities 
31,266
61,212
82,867
80,881
88,773
96,205
48,065
27,613
28,766
21,405
24,719
29,235
30,274
29,362
27,015
28,516
27,721
17,632
7,982
7,98217,63227,72128,51627,01529,36230,27429,23524,71921,40528,76627,61348,06596,20588,77380,88182,86761,21231,266
   > Total Current Liabilities 
27,028
43,600
63,640
54,796
76,004
86,681
41,043
19,456
19,256
15,055
18,623
23,582
22,306
22,328
19,673
19,793
17,806
10,199
7,868
7,86810,19917,80619,79319,67322,32822,30623,58218,62315,05519,25619,45641,04386,68176,00454,79663,64043,60027,028
       Short-term Debt 
0
0
0
0
0
0
0
0
0
5,369
1,755
6,584
4,662
8,317
5,539
0
0
329
0
0329005,5398,3174,6626,5841,7555,369000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
5,369
1,755
6,584
4,662
8,317
5,539
4,911
5,797
4,268
2,995
2,9954,2685,7974,9115,5398,3174,6626,5841,7555,369000000000
       Accounts payable 
11,260
22,484
29,881
30,611
35,699
38,007
10,958
11,328
11,297
9,224
11,678
11,902
10,967
11,000
10,871
9,815
6,445
1,742
1,343
1,3431,7426,4459,81510,87111,00010,96711,90211,6789,22411,29711,32810,95838,00735,69930,61129,88122,48411,260
       Other Current Liabilities 
11,826
9,003
15,422
3,699
3,988
8,844
5,586
4,280
4,955
4,405
4,872
3,812
1,528
1,797
1,967
2,486
3,384
4,068
7
74,0683,3842,4861,9671,7971,5283,8124,8724,4054,9554,2805,5868,8443,9883,69915,4229,00311,826
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
7,968
7,034
7,342
8,723
8,356
4,185
70
704,1858,3568,7237,3427,0347,968000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
4,415
3,234
4,508
6,461
6,686
3,260
51
513,2606,6866,4614,5083,2344,415000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-5,369
-1,755
-6,584
-4,553
-8,107
-5,379
939
979
-208
0
0-208979939-5,379-8,107-4,553-6,584-1,755-5,369000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
12
0
35
96
172
182
1
11821729635012000000000000
> Total Stockholder Equity
3,144
19,110
21,875
22,817
19,685
0
0
0
18,045
19,237
15,946
12,304
11,823
7,531
5,050
-8,407
-11,583
-1,262
-5,101
-5,101-1,262-11,583-8,4075,0507,53111,82312,30415,94619,23718,04500019,68522,81721,87519,1103,144
   Common Stock
1,375
1,745
1,761
1,776
1,761
1,788
1,788
18,000
15,716
13,000
13,000
13,000
13,000
13,970
14,990
4,180
4,302
4,484
4,491
4,4914,4844,3024,18014,99013,97013,00013,00013,00013,00015,71618,0001,7881,7881,7611,7761,7611,7451,375
   Retained Earnings 
72
3,182
5,308
6,793
4,356
0
0
1,676
2,329
6,237
2,946
-696
-1,177
-6,969
-10,450
-12,587
-17,253
-10,345
-9,592
-9,592-10,345-17,253-12,587-10,450-6,969-1,177-6962,9466,2372,3291,676004,3566,7935,3083,18272
   Capital Surplus 0000000000000000000
   Treasury Stock00000000000000-1,240-560000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
530
510
0
1,761
4,599
0
04,5991,76105105300000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue560
Cost of Revenue-56
Gross Profit504504
 
Operating Income (+$)
Gross Profit504
Operating Expense-3,339
Operating Income-3,605-2,835
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,284
Selling And Marketing Expenses0
Operating Expense3,3391,284
 
Net Interest Income (+$)
Interest Income284
Interest Expense-135
Other Finance Cost-415
Net Interest Income-266
 
Pretax Income (+$)
Operating Income-3,605
Net Interest Income-266
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,091-3,605
EBIT - interestExpense = -135
-3,988
-3,853
Interest Expense135
Earnings Before Interest and Taxes (EBIT)0-3,956
Earnings Before Interest and Taxes (EBITDA)-3,923
 
After tax Income (+$)
Income Before Tax-4,091
Tax Provision-22
Net Income From Continuing Ops-4,113-4,113
Net Income-3,988
Net Income Applicable To Common Shares-3,987
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0266
 

Technical Analysis of Bioera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioera. The general trend of Bioera is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioera.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.108 < 0.139 < 0.171.

The bearish price targets are: 0.0496 > 0.049 > 0.048.

Tweet this
Bioera Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioera. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioera Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioera. The current macd is 0.0086783.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bioera price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bioera. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bioera price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bioera Daily Moving Average Convergence/Divergence (MACD) ChartBioera Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioera. The current adx is 22.55.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bioera shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Bioera Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioera. The current sar is 0.05876006.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bioera Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioera. The current rsi is 57.19. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Bioera Daily Relative Strength Index (RSI) ChartBioera Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioera. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioera price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bioera Daily Stochastic Oscillator ChartBioera Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioera. The current cci is 93.53.

Bioera Daily Commodity Channel Index (CCI) ChartBioera Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioera. The current cmo is 14.09.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bioera Daily Chande Momentum Oscillator (CMO) ChartBioera Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioera. The current willr is -48.42931937.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bioera is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bioera Daily Williams %R ChartBioera Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bioera.

Bioera Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioera. The current atr is 0.01271544.

Bioera Daily Average True Range (ATR) ChartBioera Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioera. The current obv is 4,460,881.

Bioera Daily On-Balance Volume (OBV) ChartBioera Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioera. The current mfi is 54.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bioera Daily Money Flow Index (MFI) ChartBioera Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioera.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Bioera Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.189
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.058
Ma 100Greater thanMa 2000.055
OpenGreater thanClose0.092
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bioera with someone you think should read this too:
  • Are you bullish or bearish on Bioera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioera

I send you an email if I find something interesting about Bioera.


Comments

How you think about this?

Leave a comment

Stay informed about Bioera.

Receive notifications about Bioera in your mailbox!